Runhao

Jiangxi Runhao Pharmaceutical is a private Chinese pharmaceutical manufacturer focused on active pharmaceutical ingredients and related raw materials for global export markets. Publicly available supplier and company-profile sources describe the company as manufacturing pharmaceutical raw materials in WHO-GMP and nationally approved facilities, with production activity centered in Xiajiang County, Ji'an, Jiangxi, China. The company appears to market products such as aprotinin, chloramphenicol, florfenicol, erythromycin thiocyanate, progesterone, mifepristone, deflazacort, and betamethasone rather than an innovative clinical-stage drug pipeline. Based on the available evidence, Runhao is best characterized as a commercial API/pharmaceutical raw-material supplier rather than a biotech drug developer.